Literature DB >> 17321742

Identification, synthesis, and biological evaluation of novel pyrazoles as low molecular weight luteinizing hormone receptor agonists.

Catherine Jorand-Lebrun1, Bill Brondyk, Jing Lin, Sharad Magar, Robert Murray, Adulla Reddy, Hitesh Shroff, Greg Wands, Weishui Weiser, Qihong Xu, Sean McKenna, Nadia Brugger.   

Abstract

In the course of a high throughput screening, a series of pyrazole compounds were identified with luteinizing hormone receptor (LH-R) agonist activity. A focused pyrazole library was produced by solid-phase synthesis and key pyrazole regioisomers were obtained selectively in solution. Evaluation of those compounds in a cAMP assay in CHO cells transfected with h-LH receptor allowed us to propose a structure-activity relationship model for this series and led to the identification of the first low molecular weight molecule with in vitro activity in a Leydig cells assay (ED(50)=1.31 microM) and in vivo in a model of testosterone induction in rats (significant effect at 32 mpk ip).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17321742     DOI: 10.1016/j.bmcl.2006.12.062

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

Review 1.  Allosteric modulators of glycoprotein hormone receptors: discovery and therapeutic potential.

Authors:  Brian J Arey
Journal:  Endocrine       Date:  2008-10-28       Impact factor: 3.633

2.  A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor.

Authors:  Chris J van Koppen; Guido J R Zaman; C Marco Timmers; Jan Kelder; Sietse Mosselman; Ruud van de Lagemaat; Martin J Smit; Rob G J M Hanssen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-13       Impact factor: 3.000

Review 3.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

Review 4.  Are circulating gonadotropin isoforms naturally occurring biased agonists? Basic and therapeutic implications.

Authors:  Brian J Arey; Francisco J López
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 5.  Novel pathways in gonadotropin receptor signaling and biased agonism.

Authors:  Alfredo Ulloa-Aguirre; Pascale Crépieux; Anne Poupon; Marie-Christine Maurel; Eric Reiter
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

6.  Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice.

Authors:  Susanne Neumann; Wenwei Huang; Steve Titus; Gerd Krause; Gunnar Kleinau; Anna Teresa Alberobello; Wei Zheng; Noel T Southall; James Inglese; Christopher P Austin; Francesco S Celi; Oksana Gavrilova; Craig J Thomas; Bruce M Raaka; Marvin C Gershengorn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-10       Impact factor: 11.205

7.  Human TSH receptor ligands as pharmacological probes with potential clinical application.

Authors:  Susanne Neumann; Bruce M Raaka; Marvin C Gershengorn
Journal:  Expert Rev Endocrinol Metab       Date:  2009-11-01

Review 8.  Discovery and Development of Small Molecule Allosteric Modulators of Glycoprotein Hormone Receptors.

Authors:  Selvaraj G Nataraja; Henry N Yu; Stephen S Palmer
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-14       Impact factor: 5.555

9.  Comparative Study of the Steroidogenic Effects of Human Chorionic Gonadotropin and Thieno[2,3-D]pyrimidine-Based Allosteric Agonist of Luteinizing Hormone Receptor in Young Adult, Aging and Diabetic Male Rats.

Authors:  Andrey A Bakhtyukov; Kira V Derkach; Maxim A Gureev; Dmitry V Dar'in; Viktor N Sorokoumov; Irina V Romanova; Irina Yu Morina; Anna M Stepochkina; Alexander O Shpakov
Journal:  Int J Mol Sci       Date:  2020-10-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.